Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01693068 |
|---|---|
| Brief Title: | Phase II Trial of Pimasertib Versus Dacarbazine in N-Ras Mutated Cutaneous Melanoma |
| First Submitted : | September 14, 2012 |
| First Submitted that Met QC Criteria : | September 21, 2012 |
| First Posted : | September 26, 2012 (Estimate) |
| Results First Submitted : | October 23, 2017 |
| Results First Submitted that Met QC Criteria : | December 5, 2017 |
| Results First Posted : | January 5, 2018 |
| Last Update Submitted that Met QC Criteria : | December 5, 2017 |
| Last Update Posted : | January 5, 2018 |